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Abstract To identify regulators of the type 1A angiotensin II
receptor (AT1A), we investigated the interaction of cellular
proteins with a fusion protein containing the rat AT1A receptor
carboxyl-terminus. An V20 kDa cytoplasmic protein interacted
with the fusion protein in a Ca2+-dependent manner and was
identified as calmodulin. A control peptide with high affinity for
Ca2+/calmodulin and a peptide corresponding to a membrane
proximal portion of the AT1A receptor carboxyl-terminus with
analogy to known calmodulin-binding sequences were synthesised
and tested for calmodulin-binding. Using in vitro binding assays
combined with gel shift analysis, we demonstrated the formation
of complexes between calmodulin and both peptides, which were
Ca2+-dependent and of 1:1 stoichiometry. Affinity gels produced
from these peptides also purified calmodulin from cell extracts.
These results suggest a novel feedback regulation of the AT1A
receptor by Ca2+/calmodulin and identify the membrane
proximal region of the carboxyl-terminus as a focal point for
interactions important for AT1A receptor function.
z 1999 Federation of European Biochemical Societies.
Key words: Calmodulin-binding protein; Receptor;
Angiotensin; AT1A receptor
1. Introduction
Seven transmembrane-spanning receptors that couple to
heterotrimeric guanyl nucleotide-binding proteins (G-pro-
teins) represent a large superfamily of cell surface receptors.
These receptors convert a diverse array of sensory and hor-
monal stimuli into intracellular signals that mediate cellular
responses. The general paradigm of G-protein coupled recep-
tor (GPCR) action is that stimulated receptors undergo a
conformational change that exposes cytoplasmic domains in
the receptor, which bind to and activate G-proteins. The ter-
mination of GPCR signalling is mediated by receptor phos-
phorylation and the recruitment to the receptor of accessory
proteins termed arrestins, which prevent further G-protein
coupling and direct receptors to clathrin-coated pits for inter-
nalisation (reviewed in [1^4]).
Recent reports indicate that proteins other than heterotri-
meric G-proteins and arrestins can associate with GPCRs and
regulate their function. For example, the Na/H exchanger
regulatory factor interacts with the L2-adrenergic receptor
through a PDZ motif in the carboxyl-terminus of the receptor
[5], endothelial nitric-oxide synthase interacts with the carbox-
yl-terminus of bradykinin B2 and angiotensin AT1A receptors
[6], the small non-heterotrimeric G-proteins ARF and RhoA
associate with M3 muscarinic and angiotensin AT1 receptors
[7] and the tyrosine phosphatase SHP-1 couples to the sst2
somatostatin receptor [8]. Presumably, such associations in-
crease the repertoire of GPCR actions.
The type 1 (AT1) angiotensin receptor is a GPCR and me-
diates the important cardiovascular actions of the peptide
hormone, angiotensin II (AngII), including vasoconstriction
and blood pressure regulation, £uid and electrolyte homeo-
stasis, neuromodulation and cell growth [9]. Two closely re-
lated AT1 receptor subtypes (AT1A and AT1B) exist in rodents
and stimulation of AT1 receptors by AngII results in GKq=11
mediated signalling [10], including phospholipase C-L1-de-
pendent production of diacylglycerol and inositol(1,4,5)tris-
phosphate (IP3) with the resultant activation of protein kinase
C and release of calcium from intracellular stores. The actions
of raised intracellular calcium are mediated through small
acidic calcium-binding proteins, typi¢ed by calmodulin
(CaM), and AngII stimulation of AT1 receptors activates
Ca2/CaM-dependent kinases and pathways [11^13]. The
processes that terminate AT1 receptor signalling are also
poorly understood, but may involve the regulatory carboxyl-
terminal region, which is targeted for phosphorylation, directs
receptor internalisation and may recruit modulatory proteins
to the activated receptor [14].
To identify modulators of AT1 receptor function, the asso-
ciation of cellular proteins with the AT1A receptor carboxyl-
terminus was examined. We report a previously unrecognised
interaction between the Ca2-sensing molecule, CaM, and the
carboxyl-terminus of the AT1A receptor, which was dependent
upon the membrane proximal region of the receptor tail. This
region is a positively charged amphipathic K-helix and as such
appears to be an archetypal Ca2/CaM-binding domain. We
propose a novel feedback regulation of the AT1A receptor by
Ca2/CaM that may represent a common mechanism for reg-
ulating GPCRs.
2. Materials and methods
2.1. Production of a maltose-binding protein (MBP)-AT1A fusion
protein
A MBP fusion protein, containing amino acids 302^359 of the
AT1A receptor carboxyl-terminus (MBP-AT1ACT), was made by
PCR from the pRc/CMV/AT1A template [15] using sense (5P-
CTGCCTGAACCCTGAATTCTACGGCTTTC-3P, bold letters indi-
cate mutations) and antisense (5P-GCCAGTGTGCTGTCGACCT-
GTCACTCCAC-3P, bold letters indicate mutations) primers, incorpo-
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rating unique restriction sites (5P EcoRI and 3P SalI, underlined). The
216 bp PCR product was digested with EcoRI and SalI and ligated
into these sites of the pMal-c2 vector (New England Biolabs). To
generate a construct that produces MBP only, the pMal-c2 vector
was restriction-digested with EcoRI and XbaI, the overhangs were
¢lled-in using Klenow and the plasmid was re-ligated. This generated
an in-frame stop codon (TAG) in the polylinker region. These con-
structs were con¢rmed by sequencing.
Plasmid DNA for MBP-AT1ACT and MBP was transformed into
the TB-1 strain of Escherichia coli and cultures at A600 of 0.4^0.5 were
induced with IPTG (0.1 mM, 3 h) to stimulate fusion protein produc-
tion. Bacterial lysates were incubated with amylose resin (New Eng-
land Biolabs) and the speci¢cally bound fusion proteins eluted with
100 mM maltose. Fusion proteins were s 90% pure as judged by
SDS-PAGE. A⁄nity columns were made by applying 1 mg of puri¢ed
fusion protein to 1 ml of amylose beads and incubating for 30 min at
room temperature followed by extensive washing in Hank’s bu¡ered
salt solution (HBSS).
2.2. Interaction of 35S-labelled cellular proteins with the MBP-AT1ACT
fusion protein
Chinese hamster ovary cells (CHO-K1) cells were maintained in K-
MEM containing foetal bovine serum (10%) plus antibiotics. At 70%
con£uence, a 100 mm plate of cells was washed once with 10 ml of
DMEM devoid of L-methionine and L-cysteine and the cells were
starved in 10 ml of this media for 2 h. Cells were then incubated in
4 ml of media supplemented with 400 WCi/ml Tran35S-Label (V70%
[35S]-L-methionine, V15% [35S]-L-cysteine, ICN pharmaceuticals) for
16 h. The cells were washed three times with 10 ml of ice-cold HBSS
and lysed in 2 ml of a 50 mM Tris-HCl bu¡er, pH 7.5, containing 150
mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 1 mM phen-
ylmethylsulfonyl £uoride, 5 Wg/ml leupeptin, 1 Wg/ml aprotinin and
1 Wg/ml pepstatin. The plates were rocked for 30 min at 4‡C and cell
extracts clari¢ed by centrifugation (14 000Ug for 15 min). Typically,
80^90% of [35S] label was incorporated into protein as revealed by
precipitation with trichloroacetic acid.
Fusion proteins immobilised on amylose resin (V50 Wg protein on
50 Wl of resin) were washed twice with 1 ml of assay bu¡er (100 mM
Tris-HCl, pH 7.5, 200 mM NaCl) and then resuspended in 60 Wl of
assay bu¡er containing either 2 mM CaCl2 or 4 mM EGTA. 40 Wl of
[35S]-labelled CHO-K1 cell extract was added and the suspension was
mixed and incubated for 30 min at 22‡C. Following pelleting and
removal of the supernatant, the a⁄nity beads were washed four times
with 500 Wl of assay bu¡er containing either 4 mM EGTA or 2 mM
CaCl2. The ¢nal pellets were resuspended in 50 Wl of SDS-PAGE
sample bu¡er, heated at 95‡C for 5 min and resolved by 12% SDS-
PAGE. Gels were ¢xed and dried and apposed to a Fuji type BAS-
IIIs phosphoimaging plate for 1^3 days. The imaging plate was read
in a FUJIX Bio-imager Analyser BAS1000 to visualise the radioactive
proteins.
2.3. Preparation of peptide a⁄nity media
A peptide corresponding to the putative CaM-binding domain of
the AT1A receptor (CLGKKFKKYFLQLLKYIPPK-amide, referred
to as 1ACT, for AT1A carboxyl-terminus peptide) and the model
CaM-binding peptide (CLKLKKLLKLLKKLLKLG-amide, referred
to as CBCP, for CaM-binding control peptide) were synthesised (Chi-
ron mimotopes) with a amino-terminal cysteine to allow immobilisa-
tion on an iodoacetate-activated gel (SulfoLink Coupling gel, Pierce).
5 mg of each peptide was dissolved in 1 ml of 50 mM Tris-HCl, 5 mM
EDTA, pH 8.5 and mixed with 2 ml Sulfolink Coupling gel for
45 min at room temperature. Unbound peptide was removed by ex-
tensive washing with 50 mM Tris-HCl, 5 mM EDTA, pH 8.5 and
uncoupled iodoacetate groups in the gel were inactivated with a 50
mM cysteine wash. Finally, the column was washed with 1 M NaCl,
equilibrated with 50 mM Tris-HCl, pH 7.5 and stored as a 50%
suspension.
The method for identifying proteins that interact with the peptide
a⁄nity beads was the same as that described above for the AT1A
carboxyl-terminus fusion protein. Some SDS-PAGE gels were also
Western-blotted to a PVDF membrane (Polyscreen, NEN) and
probed with a monoclonal antibody to CaM (Upstate Biotechnology)
and visualised using Renaissance ECL (NEN). As a control, a sample
(1 ng) of pure bovine CaM (Sigma) was run in parallel to con¢rm the
immunodetection process.
2.4. In vitro binding assay and gel shift analysis
Gel shift analysis of complexes formed between CaM and 1ACT or
CBCP, using urea-polyacrylamide gel electrophoresis, was performed
as described by Erickson-Viitanen and Degrado [16]. Reactions (30 Wl)
containing 300 pmol (V5 Wg) of pure CaM and increasing amounts
(0^3000 pmol) of the peptides 1ACT or CBCP, in 100 mM Tris-HCl,
pH 7.5, 4 M urea and either 0.1 mM CaCl2 or 1 mM EGTA, were
incubated at 22‡C for 30 min. 15 Wl of a 50% glycerol/0.1% bromphe-
nol blue solution was added to each reaction and the complexes re-
solved in 12.5% acrylamide gels containing 4 M urea and either 1 mM
CaCl2 or 1 mM EGTA. The gels were ¢xed and stained with Coo-
massie blue.
3. Results and discussion
The carboxyl-terminus of the AT1 receptor is important for
receptor function. It interacts with and activates G-proteins
[17,18] and other signalling molecules [19,20], indicating a
contribution to receptor activation, while the identi¢cation
of phosphorylation sites [21,22] and internalisation motifs
[23,24] suggests a key role in receptor desensitisation. To iden-
tify possible regulators of AT1A receptor function, we inves-
tigated the interaction of [35S]-labelled cellular proteins with a
puri¢ed MBP fusion protein containing the entire receptor
carboxyl-terminus. As shown in Fig. 1, in the presence
Ca2, we observed the interaction of a small (V20 kDa)
cytoplasmic protein with the MBP-AT1ACT fusion protein
coupled to amylose resin. This interaction was not observed
with the MBP protein alone (not shown) or when Ca2 was
chelated with excess EGTA (Fig. 1). Based on its size (V20
kDa) and the Ca2-dependence of the interaction, we won-
dered whether this protein was CaM or a similar member of
the small acidic EF-hand containing family of proteins that
mediate the e¡ects of intracellular Ca2. Given that one of the
primary cellular responses to activation of the AT1 receptor
by AngII is the elevation of intracellular Ca2 levels and the
activation of Ca2/CaM-dependent pathways [11^13], we
wanted to determine if this interacting protein was CaM
and to identify the site of interaction within the AT1A carbox-
yl-terminus.
Fig. 1. Ca2-dependent interaction of proteins with the rat AT1A
carboxyl-terminus. Shown (top left) is a schematic representation of
the 359 amino acid, seven transmembrane-spanning AT1A receptor.
A maltose-binding fusion protein (MBP-AT1ACT) was constructed
that contained the entire AT1A receptor carboxyl-terminus (from
Phe300 to Glu359). This fusion protein was puri¢ed and immobilised
on amylose resin for use as an a⁄nity matrix to identify proteins
that interact with the AT1A receptor tail. In the presence of Ca2
(+), but not EGTA (3), a small V20 kDa [35S]-labelled protein (ar-
row) was found to associate with the fusion protein. This experi-
ment was repeated three times with similar results.
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Ca2-binding to CaM leads to a conformation change that
allows speci¢c binding to sequences within target proteins,
including enzymes, channels and receptors [25]. Ca2/CaM-
binding motifs in target proteins commonly involve a prepon-
derance of basically charged residues often within regions pre-
dicted to form amphipathic K-helices [25,26]. Using computer
modelling, we predicted [24] that the 54 amino acid cytoplas-
mic carboxyl-terminus of the AT1A receptor starts with Leu305
and that the region from Lys307 to Ile320 has a high proba-
bility of forming a positively-charged amphipathic K-helix.
This prediction was subsequently con¢rmed by Franzoni et
al. [27] using synthetic peptides corresponding to this region
examined by circular dichroism and nuclear magnetic reso-
nance. Shown in Fig. 2 is the helical wheel projection of
this region, which reveals an amphipathic nature characteristic
of a CaM-binding site. For comparison, the helical wheel
projection of the model CaM-binding peptide (CBCP,
Kd =V2 nM for CaM, [28]) and an alignment of the two
peptide sequences is shown.
To determine if this basic amphipathic helical region of the
AT1A receptor carboxyl-terminus was su⁄cient to a⁄nity pu-
rify the V20 kDa Ca2-dependent protein and could function
as a possible CaM-binding site, we coupled the synthetic pep-
tides (1ACT and CBCP) to SulphoLink gel matrix and used
these peptide a⁄nity gels to identify interacting [35S]-labelled
proteins. As shown in Fig. 3, the CBCP a⁄nity gel puri¢ed an
V20 kDa protein and this association was lost when Ca2
was chelated with EGTA. Similarly, the 1ACT a⁄nity matrix
enriched a cytoplasmic protein of V20 kDa in a Ca2-de-
pendent manner. Western blot analysis, using a monoclonal
CaM antibody that does not cross-react with other small
Ca2-binding proteins (S100K, S100L, tropinin C and parval-
bumin), identi¢ed this protein as CaM (Fig. 4).
To determine if the peptide 1ACT (residues 305^327 of the
rat AT1A receptor) forms a high a⁄nity complex with Ca2/
CaM, polyacrylamide gel electrophoresis in the presence of
4 M urea was performed. This procedure identi¢es only high
a⁄nity interactions (Kd6 100 nM) because 4 M urea dissoci-
ates low a⁄nity and non-speci¢c complexes [16]. The stoichi-
ometry of binding was determined by incubating a constant
amount of pure CaM (300 pmol) with increasing concentra-
tions (0^3000 pmol) of either 1ACT or the control (CBCP)
synthetic peptides. Shown in Fig. 5 are Coomassie blue-
stained gels of the gel shift titration experiment. In the pres-
ence of Ca2, the addition of either CBCP or 1ACT resulted
in a decreased mobility (upward shift) of CaM indicating the
formation of high a⁄nity complexes between CaM and the
peptides. The gel shift was complete at equimolar amounts of
CaM and peptide (300 pmol) and further addition of peptide
did not result in additional bands, which would suggest multi-
valent complexes. No complexes were formed when Ca2 was
Fig. 2. The proximal AT1A carboxyl-terminus is a positively charged
amphipathic helix. Shown are an alignment of residues 305^327 of
the rat AT1A carboxyl-terminus and a leucine/lysine repeating pep-
tide that forms a perfect amphipathic helix with nM a⁄nity for
calmodulin [28]. Identical and similar residues are indicated by lines
and dashed lines, respectively. Shown below are the helical wheel
representations for the AT1A receptor carboxyl-terminus peptide
(termed 1ACT) and the CBCP (termed CBCP). Note, the similarity
in charge and amphipathicity of the receptor sequence and the con-
trol peptide.
Fig. 3. Ca2-dependent interaction of proteins with 1ACT and
CBCP peptide a⁄nity gels. The 1ACT and CBCP peptides were co-
valently attached through an introduced N-terminal cysteine to Sul-
phoLink coupling gel. The resulting a⁄nity gels were used to identi-
fy interacting [35S]-labelled proteins. In the presence of Ca2 (+),
but not EGTA (3), an V20 kDa [35S]-labelled protein (arrow) was
found to associate with both the 1ACT and CBCP a⁄nity gels.
This experiment was performed four times with similar results.
Fig. 4. Western blot analysis identi¢es the 20 kDa interacting pro-
tein as CaM. CHO-K1 cell extracts were puri¢ed over the 1ACT
and CBCP a⁄nity matrices, separated by SDS-PAGE and Western-
blotted with an monoclonal CaM antibody. 1 ng of puri¢ed bovine
CaM was run as a positive control (arrow). Immunoreactive CaM,
with a migration similar to the control CaM, was bound in a Ca2-
speci¢c manner by both peptide a⁄nity gels. This experiment was
performed three times with similar results.
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chelated by EGTA, regardless of the amount of peptide
added. These data indicate a single, high a⁄nity, Ca2-de-
pendent binding site for CBCP and 1ACT on CaM.
Our observation of a high a⁄nity CaM-binding site in the
proximal region of the AT1A receptor carboxyl-terminus has
important implications for receptor function. We propose the
following feedback loop between the AT1A receptor and Ca2/
CaM: AngII-stimulated AT1A receptors promote release of
Ca2 from intracellular stores, which generates activated
Ca2/CaM complexes. These complexes then feedback to
bind the basically charged, amphipathic helical region encom-
passing residues 305^320 within the AT1A receptor carboxyl-
terminus. The proposed CaM feedback is analogous to the
feedback pathways reported for other Ca2-mobilizing recep-
tors and channels (e.g. the inhibition of the N-methyl-D-aspar-
tate receptor [29], the CaM regulation of the transient recep-
tor potential-like channel and the negative regulation of
phototransduction, which occurs at the level of the rhodopsin
receptor [30]).
The role of this putative CaM-AT1A receptor feedback loop
is unknown, but the proximal carboxyl-terminus (residues
305^322) has been implicated in a number of important
AT1A receptor functions. Foremost, this region is involved
in binding and activating heterotrimeric G-proteins [17,18]
and point mutations of Tyr312, Phe313 and Leu314 uncouple
the receptor from G-protein-dependent signalling. It is there-
fore tempting to speculate that once the AngII-stimulated
AT1A receptor has activated and released the heterotrimeric
G-protein to initiate signalling, the subsequent Ca2 transient
results in Ca2/CaM recruitment to the G-protein-binding site
to prevent re-association of G-protein with the receptor. In
such a scenario, Ca2/CaM-binding would be predicted to
produce a form of receptor desensitisation. We have also re-
ported that mutations of hydrophobic amino acids at the end
of this amphipathic K-helix dramatically reduce AT1A recep-
tor internalisation [24] and Gaborik et al. [31] have linked the
region Lys307^Lys311 to cell surface expression, suggesting that
important determinants of receptor tra⁄cking are associated
with this helical region. Interestingly, Ca2/CaM has been
implicated in the general process of receptor endocytosis
and, more speci¢cally, in the internalisation of another
GPCR, the serotonin receptor [32]. Whether, CaM-binding
to the AT1A receptor is involved in receptor internalisation
remains to be determined. Finally, the sequence Tyr319^
Pro322 reportedly binds phospholipase C-Q1 and a complex
of SHP-2 phosphatase/Jak2 kinase [19,20], suggesting a mech-
anism for the activation of growth factor-like tyrosine kinase
signalling pathways by the AT1A receptor [10,33]. Clearly, this
region of the carboxyl-terminus is multifaceted, which sug-
gests a complex hierarchy of interactions central to AT1A
receptor function.
In conclusion, we have identi¢ed, for the ¢rst time, the
presence of a CaM-binding site within the carboxyl-terminus
of the G-protein-coupled AT1A receptor. This high a⁄nity,
Ca2-dependent binding domain is a basic amphipathic K-he-
lix and therefore bears all the hallmarks of a genuine CaM
regulatory site. The recent identi¢cation of Ca2/CaM-binding
sites within the carboxyl-terminus of another seven transmem-
brane-spanning GPCR, namely the metabotropic glutamate
receptor subtype 5 [34], predicts that Ca2/CaM-binding to,
and modulation of, GPCRs may be a widespread phenom-
enon. CaM can also regulate the GPCR kinases [35] which
phosphorylate these receptors and CaM-dependent protein
kinases phosphorylate and modulate the activity of the arrest-
in proteins [36], which bind to phosphorylated GPCRs and
lead to their desensitisation and internalisation. Together,
these data identify CaM as a primary regulator of GPCR
function.
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